Patents Assigned to ABBVIE STEMCENTRX LLC
  • NOVEL ANTI-BMPR1B ANTIBODIES AND METHODS OF USE
    Publication number: 20210261670
    Abstract: Provided are novel anti-BMPR1B antibodies and antibody drug conjugates, and methods of using such anti-BMPR1B antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: January 29, 2021
    Publication date: August 26, 2021
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SOMDUTTA ROY, LAURA SAUNDERS, CASEY FRANKLIN, KEVIN MARTINEZ, SARAH FONG, ZHAO HUANG, SILVIA JUAREZ, ALINA HE, KATHRYN A. LOVING, SANDRO VIVONA
  • Anti-SEZ6 antibody drug conjugates and methods of use
    Patent number: 11077203
    Abstract: Provided are novel anti-SEZ6 antibodies and antibody drug conjugates, and methods of using such anti-SEZ6 antibodies and antibody drug conjugates to treat cancer.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: August 3, 2021
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: David Liu, Julia Gavrilyuk, Alexander Schammel
  • Light chain variable regions
    Patent number: 11033634
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: June 15, 2021
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-BMPR1B antibodies and methods of use
    Patent number: 10934359
    Abstract: Provided are novel anti-BMPR1B antibodies and antibody drug conjugates, and methods of using such anti-BMPR1B antibodies and antibody drug conjugates to treat cancer.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: March 2, 2021
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Somdutta Roy, Laura Saunders, Casey Franklin, Kevin Martinez, Sarah Fong, Zhao Huang, Silvia Juarez, Alina He, Kathryn A. Loving, Sandro Vivona
  • Anti-PTK7 antibodies and methods of use
    Patent number: 10836831
    Abstract: Anti-PTK7 modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: November 17, 2020
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Orit Foord, Scott J. Dylla, Robert A. Stull, Alex Bankovich, Alexandra Leida Liana Lazetic, Jeffrey Bernstein
  • ANTI SEZ6 ANTIBODIES AND METHODS OF USE
    Publication number: 20200181256
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: December 12, 2019
    Publication date: June 11, 2020
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, ROBERT A. STULL, MICHAEL TORGOV, HUI SHAO, DAVID LIU
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20200138969
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: December 6, 2019
    Publication date: May 7, 2020
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti SEZ6 antibodies and methods of use
    Patent number: 10533051
    Abstract: Provided are novel seizure related 6 (SEZ6) modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: January 14, 2020
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Laura Saunders, Scott J. Dylla, Orit Foord, Robert A. Stull, Michael Torgov, Hui Shao, David Liu
  • Anti-DLL3 antibody drug conjugates for treating cancer
    Patent number: 10478509
    Abstract: Provided are novel antibody drug conjugates (ADCs), and methods of using such ADCs to treat proliferative disorders.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: November 19, 2019
    Assignees: ABBVIE STEMCENTRX LLC, MEDIMMUNE LIMITED
    Inventors: Michael Torgov, Philip Wilson Howard
  • Anti-MFI2 antibodies and methods of use
    Patent number: 10428156
    Abstract: Provided are novel anti-MFI2 antibodies and antibody drug conjugates, and methods of using such anti-MFI2 antibodies and antibody drug conjugates to treat cancer.
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: October 1, 2019
    Assignee: Abbvie Stemcentrx LLC
    Inventors: Samuel Williams, Laura Saunders, Holger Karsunky, Mandy Boontanrart
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20190247510
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: April 12, 2019
    Publication date: August 15, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • ANTI-DLL3 ANTIBODY DRUG CONJUGATES AND METHODS OF USE
    Publication number: 20190225685
    Abstract: Provided are novel anti-DLL3 antibodies and antibody drug conjugates, and methods of using such anti-DLL3 antibodies and antibody drug conjugates to treat brain cancer.
    Type: Application
    Filed: January 24, 2019
    Publication date: July 25, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: KUMIKO ISSE, LAURA SAUNDERS
  • ANTI-DLL3 DRUG CONJUGATES FOR TREATING TUMORS AT RISK OF NEUROENDOCRINE TRANSITION
    Publication number: 20190201542
    Abstract: Methods of treating tumors at risk for neuroendocrine transition using anti-delta-like ligand 3 (DLL3) antibody drug conjugates (ADCs) are provided.
    Type: Application
    Filed: May 19, 2017
    Publication date: July 4, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Laura SAUNDERS, Robert A. STULL, Daniel R. HYDUKE, Enying YOU
  • ANTI-ASCL1 ANTIBODIES AND METHODS OF USE
    Publication number: 20190194319
    Abstract: Compositions comprising Achaete-scute homolog 1 (ASCL1) antibodies, and methods comprising ASCL1 antibody compositions for detecting ASCL1 expression as a diagnostic biomarker, are provided.
    Type: Application
    Filed: May 19, 2017
    Publication date: June 27, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: JEFFREY BERNSTEIN, LAURA SAUNDERS, SHEILA BHEDDAH, ENYING YOU, CASEY FRANKLIN, TIEN YIN YAU, GRAYSON KOCHI
  • Anti-DLL3 antibodies and drug conjugates for use in melanoma
    Patent number: 10308721
    Abstract: Anti-DLL3 antibodies and antibody drug conjugates for use in the diagnosis and treatment of melanoma.
    Type: Grant
    Filed: February 23, 2015
    Date of Patent: June 4, 2019
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Samuel Williams, Laura Saunders, Kathryn A Loving
  • NOVEL ANTI-BMPR1B ANTIBODIES AND METHODS OF USE
    Publication number: 20190153103
    Abstract: Provided are novel anti-BMPR1B antibodies and antibody drug conjugates, and methods of using such anti-BMPR1B antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: April 21, 2017
    Publication date: May 23, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SOMDUTTA ROY, LAURA SAUNDERS, CASEY FRANKLIN, KEVIN MARTINEZ, SARAH FONG, ZHAO HUANG, SILVIA JUAREZ, ALINA HE, KATHRYN A. LOVING, SANDRO VIVONA
  • NOVEL ANTI-TNFRSF21 ANTIBODIES AND METHODS OF USE
    Publication number: 20190127476
    Abstract: Provided are novel anti-TNFRSF21 antibodies and antibody drug conjugates, and methods of using such anti-TNFRSF21 antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: May 5, 2017
    Publication date: May 2, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: LAURA SAUNDERS, DEEPTI ROKKAM, DAVID LIU, MANDY BOONTANRART, ALEXANDER JOHN BANKOVICH, EVAN BISHOP, MONETTE AUJAY, ZHAO HUANG
  • NOVEL ANTI-CLAUDIN ANTIBODIES AND METHODS OF USE
    Publication number: 20190083645
    Abstract: Provided herein are novel anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: December 2, 2016
    Publication date: March 21, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SARAH FONG, VIKRAM NATWARSINHJI SISODIYA, ROBERT A. STULL, SAMUEL A. WILLIAMS
  • NOVEL ANTI-CLAUDIN ANTIBODIES AND METHODS OF USE
    Publication number: 20190077876
    Abstract: Provided herein are novel anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: August 20, 2018
    Publication date: March 14, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Marianne SANTAGUIDA, Monette AUJAY, Laura SAUNDERS, David LIU, Orit FOORD, Robert A. STULL, Paul Anthony ESCARPE
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20190046656
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: October 25, 2018
    Publication date: February 14, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao